Gotoh, A <br/><br/>
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy.  [electronic resource] 

 -  Microbiology and immunology  1997 
 - 7-12 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0385-5600 
<br/><br/><label>Standard No.: </label>10.1111/j.1348-0421.1997.tb01166.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Adolescent<br/>Adult<br/>Aged<br/>Amoxicillin--pharmacology<br/>Anti-Bacterial Agents--pharmacology<br/>Clarithromycin--pharmacology<br/>Drug Resistance, Microbial<br/>Drug Therapy, Combination<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori--drug effects<br/>Humans<br/>Lansoprazole<br/>Male<br/>Metronidazole--pharmacology<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Omeprazole--analogs & derivatives